Live Breaking News & Updates on Acorn pharmaceuticals
Stay updated with breaking news from Acorn pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
it can turn it into a vapor. the problem is that this drug, until recently, was manufactured by three companies in the united states. one of those companies was shut down basically for manufacturing issues. as you said, acorn pharmaceuticals that was manufacturing albuterol shut down their illinois plant after they declared bankruptcy. that was the plant that manufactured this agent. that leaves only one company in the united states to produce albuterol. there are 25 million people in this country with asthma. there are about a million and a half e.r. visits every year for this very common issue. it kills 4,000 people a year. almost all those deaths are preventible. this is a crucial drug. it sort of underscores the fragility of the u.s. drug generic pipeline. >> can we get into a situation where there are shortages because people are trying to get as much of this albuterol that
Insights on the Body Worn Insect Repellent Global Market to 2027 - Featuring Acorn Pharmaceuticals, All Terrain & Avon Products Among Others January 20, 2021 05:08 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 8th edition of this report. The 183-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Body Worn Insect Repellent Market to Reach $626.4 Million by 2027 Amid the COVID-19 crisis, the global market for Body Worn Insect Repellent estimated at US$364.6 Million in the year 2020, is projected to reach a revised size of US$626.4 Million by 2027, growing at a CAGR of 8% over the analysis period 2020-2027.